Search for: "BIOGEN IDEC U.S."
Results 1 - 20
of 69
Sorted by Relevance
|
Sort by Date
30 Sep 2009, 8:15 pm
Patent 7,588,755 (the '755 patent), issued on September 15, 2009, and owned by Biogen Idec. [read post]
17 Apr 2013, 9:59 pm
By Donald Zuhn -- Yesterday, in Biogen Idec, Inc. v. [read post]
8 Sep 2011, 9:59 pm
Biogen IDEC is a separate explication of "additional views" by Chief Judge Rader (at right) joined by Judge Newman. [read post]
11 Mar 2016, 9:16 am
Biogen IDEC International AG changed its name to Biogen IDEC International GMBH on May 15, 2007. [read post]
28 Mar 2010, 8:33 pm
Biogen Idec, Inc. et al. v. [read post]
19 Dec 2008, 9:20 pm
Biogen IDEC. [read post]
31 Aug 2011, 1:27 pm
Biogen Idec (Fed. [read post]
20 Sep 2011, 9:59 pm
Biogen Idec. and Association for Molecular Pathology v. [read post]
16 Apr 2013, 8:30 pm
” Biogen, 2011 U.S. [read post]
17 Aug 2010, 9:52 pm
Biogen Idec, and Association for Molecular Pathology v. [read post]
22 Dec 2008, 11:28 pm
Noonan -- The Federal Circuit engaged in judicial parsimony last week, in affirming the decision below that the asserted claims of U.S. [read post]
11 May 2016, 2:05 pm
We start with the apparent increase in the number of Tecfidera - PML cases that have been reported to Biogen Idec and/or the FDA. [read post]
31 Aug 2011, 9:56 pm
Biogen IDEC et al., Nos. 2006-1634, -1649 (Fed. [read post]
2 Oct 2022, 4:55 pm
Biogen Idec, Inc., No. 12-cv-10601-IT (D. [read post]
29 Jun 2010, 9:19 am
Biogen IDEC et al. (08-1509) The petition for a writ of certiorari is granted. [read post]
30 Jul 2018, 7:17 am
Biogen Idec Inc., 2-10-cv-02734 (NJD July 26, 2018, Order) (Cecchi, MJ) [read post]
24 May 2009, 10:58 pm
In the case IN RE GENENTECH, INC. and BIOGEN IDEC INC., the petitioners sought, and obtained, a writ of mandamus to move the patent case from ED Texas to ND California. [read post]
4 May 2007, 2:56 pm
Biogen Idec Inc. and Elan Corp., also said there were no reports of other "serious opportunistic infections," as of April 23. [read post]
17 Apr 2007, 1:18 am
Cytochroma Inc. et al., case number 06-C-0428, in the U.S. [read post]
8 Apr 2009, 11:47 am
There will be a phased voluntary withdrawal of psoriasis drug Raptiva from the U.S. market due to its link to a brain infection.Raptiva has recently been associated with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal disease of the central nervous system.Authorities in Europe, where Raptiva is sold by Merck KGaA (MRCG.DE), recommended in February that the drug be suspended in light of the PML risk.The European Commission is expected to follow… [read post]
